WHO ICTRP trial
Dose proportional study after single doses intranasal administration of NRL-1 in…
JPRN-jRCT2031220272 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT2031220272 |
|---|---|
| Public title | Dose proportional study after single doses intranasal administration of NRL-1 in healthy Japanese subjects |
| Scientific title | A Phase 1, randomized, open-label, three-period crossover study to evaluate pharmacokinetics, dose proportionality, and safety after single intranasal administration of NRL-1 (diazepam, spray) in healthy Japanese subjects |
| Primary sponsor | Takazawa Kenji |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 1 |
| Conditions | status epilepticus or seizures that may progress to status epilepticus |
| Interventions | Single intranasal administration of NRL-1 (diazepam, spray) |
| Registration date | Aug 15, 2022 |
| Target size | 30 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: